Editors: Atta-ur-Rahman, FRS , M. Iqbal Choudhary

Frontiers in Anti-Cancer Drug Discovery

Volume 9

eBook: US $99 Special Offer (PDF + Printed Copy): US $168
Printed Copy: US $119
Library License: US $396
ISSN: 2451-8395 (Print)
ISSN: 1879-6656 (Online)
ISBN: 978-1-68108-702-3 (Print)
ISBN: 978-1-68108-701-6 (Online)
Year of Publication: 2018
DOI: 10.2174/97816810870161180901


Frontiers in Anti-Cancer Drug Discovery is a book series devoted to publishing the latest advances in anti-cancer drug design and discovery. In each volume, eminent scientists contribute reviews relevant to all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The book series should prove to be of interest to all pharmaceutical scientists involved in research in anti-cancer drug design and discovery. The book series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.

The ninth volume of the series features chapters covering the following topics: - New research on the therapeutic intervention of cancer and cancer drug delivery - Dabrafenib usage in melanoma therapy - Targeting autophagy in cancer therapy - Pro-apoptotic and anti-telomerase activity of naturally occurring compounds - CDK inhibitors - Oral nanostructure drug delivery for anti-cancer treatment


- Pp. i-iii (3)
Atta-ur-Rahman, M. Iqbal Choudhary
Download Free

List of Contributors

- Pp. iv-v (2)
Atta-ur-Rahman, M. Iqbal Choudhary
Download Free

Recent Advances and New Insights for the Therapeutic Intervention of Cancer

- Pp. 1-63 (63)
Nhi Nguyen, Stina George Fernandes, Ekta Khattar, Yinghui Li
View Abstract

Dabrafenib in Melanoma

- Pp. 64-90 (27)
Meredith McKean, Rodabe N. Amaria
View Abstract

Targeting Autophagy in Cancer Therapy

- Pp. 91-113 (23)
Maria Ines Vaccaro, Claudio Daniel Gonzalez
View Abstract

Selective Anti-Cancer Drugs against Multi-drug Resistance

- Pp. 114-192 (79)
Tijana Stankovic, Ana Podolski-Renic, Jelena Dinic, Milica Pesic
View Abstract

Pro-Apoptotic and Anti-Telomerase Activity of Naturally Occurring Compounds

- Pp. 193-233 (41)
Mahendar Porika, Radhika Tippani, Nazneen Firdous
View Abstract

The Prospects of CDK Targeting and Clinical Application of CDK Inhibitors in Cancer

- Pp. 234-286 (53)
Aditi Gangopadhyay, Aparna Gangopadhyay
View Abstract

Advancements in Anticancer Drug Delivery

- Pp. 287-314 (28)
Hemant K.S. Yadav, Abrar E. Srouji, Alyazya Mohammed, Manar Dibi
View Abstract

Subject Index

- Pp. 315-324 (10)
Atta-ur-Rahman, M. Iqbal Choudhary
Download Free